News & Updates

Tenofovir alafenamide may prevent HBV mother-to-child transmission

19 Aug 2021 by

Tenofovir alafenamide (TAF), administered during the second or third trimester of pregnancy, may prevent mother-to-child transmission (MTCT) of hepatitis B virus (HBV) infection, according to two studies presented as posters at ILC 2021.

Tenofovir alafenamide may prevent HBV mother-to-child transmission

19 Aug 2021

CREDO 1: Novel biologic for rheumatoid arthritis hits mark

19 Aug 2021 by

Treatment with olokizumab yields significant improvements in signs and symptoms of rheumatoid arthritis (RA), particularly among patients with active disease despite receipt of an adequate dose of methotrexate, according to the results of the phase III CREDO 1 trial.

CREDO 1: Novel biologic for rheumatoid arthritis hits mark

19 Aug 2021

Botulinum toxin type A may reduce incontinence episodes

19 Aug 2021 by

In a systematic review and meta-analysis of randomized controlled trials (RCTs) presented at EAU 2021, the use of botulinum toxin (BTX) type A in individuals with neurogenic detrusor overactivity (NDO) and idiopathic overactive bladder (iOAB) led to a reduction in incontinence episodes.

Botulinum toxin type A may reduce incontinence episodes

19 Aug 2021

Ondansetron reduces IV fluid administration in paediatric gastroenteritis

18 Aug 2021

Use of oral ondansetron in the treatment of children with gastroenteritis who seek emergency department (ED) care works to reduce index ED visit intravenous (IV) fluid administration, a study has found. The drug has null effects on other outcomes.

Ondansetron reduces IV fluid administration in paediatric gastroenteritis

18 Aug 2021

Once-weekly DPP-4 inhibitor delivers in type 2 diabetes

18 Aug 2021

Switching from once-daily to once-weekly dipeptidyl peptidase 4 (DPP-4) inhibitors works to maintain fasting plasma glucose and time in range in patients with type 2 diabetes mellitus, a study has shown.

Once-weekly DPP-4 inhibitor delivers in type 2 diabetes

18 Aug 2021

Original New Drug Application Approvals by US FDA (01-15 August 2021)

18 Aug 2021

New drug applications approved by US FDA as of 01-15 August 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 August 2021)

18 Aug 2021

MV140 bacterial vaccine reduces UTI frequency in women

18 Aug 2021 by

The sublingual bacterial vaccine MV140 reduces the number of recurrent urinary tract infections (UTIs) in women, according to a European study presented at EAU21.

MV140 bacterial vaccine reduces UTI frequency in women

18 Aug 2021

Effective therapeutic options needed for M abscessus pulmonary disease, study says

17 Aug 2021 by

A multidrug regimen containing inhaled amikacin with or without clofazimine improves outcomes in patients with pulmonary disease (PD) caused by Mycobacterium abscessus subspecies massiliense, according to a study. However, the regimen shows only moderate efficacy in treating infections with the abscessus subspecies.

Effective therapeutic options needed for M abscessus pulmonary disease, study says

17 Aug 2021

Moderna vaccine safe, effective in adolescents

17 Aug 2021 by

The mRNA-1273 SARS-CoV-2 vaccine developed by Moderna demonstrates satisfactory safety profile in adolescents and produces an immune response comparable to that in young adults, according to the results of an interim analysis of an ongoing trial.

Moderna vaccine safe, effective in adolescents

17 Aug 2021

Statins proven safe, effective for HCC prevention in chronic liver disease patients

17 Aug 2021

Use of statins is safe and may even reduce the risk of developing hepatocellular carcinoma (HCC) among adults with chronic liver disease, a recent study has shown.

Statins proven safe, effective for HCC prevention in chronic liver disease patients

17 Aug 2021

News & Updates

Filter by Specialty:

Specialty:

Tenofovir alafenamide may prevent HBV mother-to-child transmission

Tenofovir alafenamide may prevent HBV mother-to-child transmission

CREDO 1: Novel biologic for rheumatoid arthritis hits mark

CREDO 1: Novel biologic for rheumatoid arthritis hits mark

Botulinum toxin type A may reduce incontinence episodes

Botulinum toxin type A may reduce incontinence episodes

Ondansetron reduces IV fluid administration in paediatric gastroenteritis

Ondansetron reduces IV fluid administration in paediatric gastroenteritis

Once-weekly DPP-4 inhibitor delivers in type 2 diabetes

Once-weekly DPP-4 inhibitor delivers in type 2 diabetes

Original New Drug Application Approvals by US FDA (01-15 August 2021)

Original New Drug Application Approvals by US FDA (01-15 August 2021)

MV140 bacterial vaccine reduces UTI frequency in women

MV140 bacterial vaccine reduces UTI frequency in women

Effective therapeutic options needed for M abscessus pulmonary disease, study says

Effective therapeutic options needed for M abscessus pulmonary disease, study says

Moderna vaccine safe, effective in adolescents

Moderna vaccine safe, effective in adolescents

Statins proven safe, effective for HCC prevention in chronic liver disease patients

Statins proven safe, effective for HCC prevention in chronic liver disease patients